You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, October 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intravenous Metyrapone Test in Chromophobe Adenoma

BYONG S. MIN, MD; V. WILLIAM COLE, MD

Arch Intern Med. 1965;116(4):581-585.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

BECAUSE of the recent innovation of the metyrapone test as a measure of endogenous ACTH reserve,1,2 methodological variations on this technique have not been clarified. The dosage, route, and time of day the drug is administered are as important to the final result of the test as is the selection of the appropriate steroid analytical procedures.3 The paucity of reports concerning use of the intravenous route of administration and the current controversy over the results even in normal individuals 4 prompt us to report our experience.

This study documents the findings in control subjects and in patients with chromophobe adenoma of the pituitary gland. Increments in the total urinary Porter-Silber chromogens which occurred after the administration of intravenous metyrapone were employed as an indirect measure of pituitary adrenocorticotrophic hormone (ACTH) reserve.

Materials and Methods

Thirteen control subjects and eighteen patients with chromophobe adenoma seen at The University . . . [Full Text PDF of this Article]


Author Affiliations

HOUSTON

From the University of Texas M. D. Anderson Hospital and Tumor Institute. Associate Internist Department of Medicine (Dr. Cole). Clinical fellow, American Cancer Society, 1963-1964, and presently at Catholic Medical College, St. Mary's Hospital, Seoul, Korea (Dr. Min).


Footnotes

Received for publication Sept 29, 1964; accepted March 29, 1965.

Reprint requests to University of Texas M. D. Anderson Hospital and Tumor Institute, Bertner Dr, Houston, Tex 77025 (Dr. Cole).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.